Advertisement

Table of Contents

January 28, 2016; 127 (4)

BLOOD FLASHBACK

INSIDE BLOOD COMMENTARIES

PLENARY PAPER

PERSPECTIVES

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

  • A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
    Harriet S. Walter, Simon A. Rule, Martin J. S. Dyer, Lionel Karlin, Ceri Jones, Bruno Cazin, Philippe Quittet, Nimish Shah, Claire V. Hutchinson, Hideyuki Honda, Kevin Duffy, Joseph Birkett, Virginia Jamieson, Nigel Courtenay-Luck, Toshio Yoshizawa, John Sharpe, Tomoya Ohno, Shinichiro Abe, Akihisa Nishimura, Guillaume Cartron, Franck Morschhauser, Christopher Fegan and Gilles Salles
  • Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM
    María-Victoria Mateos, Joaquín Martínez-López, Miguel-Teodoro Hernández, Enrique-M. Ocio, Laura Rosiñol, Rafael Martínez, Ana-Isabel Teruel, Norma C. Gutiérrez, María-Luisa Martín Ramos, Albert Oriol, Joan Bargay, Enrique Bengoechea, Yolanda González, Jaime Pérez de Oteyza, Mercedes Gironella, Cristina Encinas, Jesús Martín, Carmen Cabrera, Bruno Paiva, María-Teresa Cedena, Noemí Puig, Joan Bladé, Juan-José Lahuerta and Jesús San-Miguel

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSFUSION MEDICINE

TRANSPLANTATION

BLOOD WORK